Related Experiment Videos
Experimental esophagitis in a rabbit model. Clinical relevance
Journal of Clinical Gastroenterology
|January 1, 1986
Summary
Proteolytic enzymes, not acid or bile salts, cause severe esophagitis. Sucralfate protects the esophagus from acid-pepsin injury, suggesting new therapeutic targets for reflux esophagitis.
Area of Science:
- Gastroenterology
- Esophageal Physiology
- Reflux Disease Research
Background:
- Gastroesophageal reflux, involving excess acid and/or alkaline substances, is linked to esophagitis.
- Understanding the specific agents causing esophageal injury is crucial for effective treatment.
Purpose of the Study:
- To investigate the role of endogenous injurious agents in causing esophageal mucosal damage.
- To develop and utilize a rabbit esophageal model for studying reflux esophagitis.
Main Methods:
- A continuously perfused in vivo rabbit esophageal model was employed.
- The effects of hydrochloric acid (HCl), bile salts, pepsin, and trypsin on esophageal mucosa were assessed.
Main Results:
- Physiologic HCl did not breach the mucosal barrier or cause esophagitis.
- Bile salts disrupted the mucosal barrier but did not induce clinically consistent esophagitis.
- Pepsin (acidic) and trypsin (alkaline) induced severe hemorrhagic erosive esophagitis, mirroring clinical findings.
- Sucralfate demonstrated mucosal protective effects against acid-pepsin injury.
Conclusions:
- Proteolytic enzymes are the primary agents responsible for severe reflux esophagitis.
- Therapeutic strategies should target proteolytic enzymes, not solely acid or bile salts.
- Sucralfate shows promise as a protective agent against specific reflux-induced esophageal injuries.